FDA Drug recall D-0652-2016
Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0404-15, UPC 305740404157
- FDA Drug
- Class II
- terminated
- Published 2016-02-10
On 2016-02-10 the FDA classified a Class II recall of Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0404-15, UPC 305740404157 by Perrigo, citing labeling: label error on declared strength.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0652-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-01-18 |
| Published | 2016-02-10 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Perrigo |
| Distribution | US |
Product
Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0404-15, UPC 305740404157
Reason
Labeling: label error on declared strength.
Identifiers
| upc | 305740404157 |
|---|---|
| code_info | Lot #: 2015080484, Exp 02/2016 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0652-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.